UPDATE : Tuesday, April 7, 2020
상단여백
GC’s sales rose but profits fell in 2019
GC said Wednesday it recorded sales of 1.36 trillion won ($1.1 billion) las...
by Lee Han-soo  |  2020-02-12 11:40
라인
Medipost’s sales edge up, losses widen last year
Medipost said Wednesday that the company’s operating and net losses magnifi...
by Lee Han-soo  |  2020-02-12 11:40
라인
MSD Korea workers unhappy with spinoff plan
After MSD announced its “strategy” to separate some medicines under a new c...
by Kim Yun-mi  |  2020-02-11 14:57
라인
Fake news about new coronavirus drug candidate goes viral
Dubious reports are circulating in Korea claiming that a Chinese research i...
by Kim Yun-mi  |  2020-02-11 12:33
라인
Novartis' new drug for mutated lung cancer gets insurance coverage
A combined modality therapy of Rafinlar (ingredient: dabrafenib) and Meqsel...
by Kim Yun-mi  |  2020-02-10 18:29
라인
Hanmi Pharmaceutical renews yearly profit records
Hanmi Pharmaceutical said that it recorded 1.11 trillion won ($937 million)...
by Shim Hyun-tai  |  2020-02-10 12:29
라인
Court acquits Nature Cell president of stock manipulation
The Seoul Southern District Prosecutor Office Friday acquitted Nature Cell ...
by Jeong Sae-im  |  2020-02-07 18:40
라인
Handok’s medicine for childhood hypophosphatasia gets insurance benefits
Handok's Strensiq (ingredient: asfotase alfa), a medicine for childhood...
by Kim Eun-young  |  2020-02-07 15:59
라인
AstraZeneca Korea leaves umbrella trade union
AstraZeneca Korea’s branch of the Korea Democratic Pharmaceutical Union sai...
by Jeong Sae-im  |  2020-02-07 14:35
라인
Experts caution against hasty use of Olumiant for new coronavirus
Although a British artificial intelligence (AI) developer said Eli Lilly’s ...
by Kim Yun-mi  |  2020-02-06 16:08
라인
MSD to spin off women’s health, biosimilars under new firm
MSD said it would concentrate on oncology drugs and vaccines and establish ...
by Kim Yun-mi  |  2020-02-06 13:07
라인
Helixmith presents study results of neuropathic pain treatment
Helixmith unveiled the outcome of its study on developing a treatment for p...
by Shim Hyun-tai  |  2020-02-05 18:43
라인
‘Baricitinib emerges as potential treatment for new coronavirus’
Benevolent AI, a U.K.-based artificial intelligence (AI) healthcare firm, h...
by Lee Han-soo  |  2020-02-05 16:32
라인
Medytox, Daewoong in final battle over BTX strain ownership
The legal dispute between Medytox and Daewoong Pharmaceutical over the sour...
by Jeong Sae-im  |  2020-02-05 12:41
라인
Interferon, Kaletra to get insurance benefit for new coronavirus treatment
The government said it would allow health insurance benefits for patients w...
by Kim Yun-mi  |  2020-02-04 16:39
라인
‘Gilead’s drug candidate effective to fight new coronavirus’
Gilead Sciences’ antiviral drug candidate, remdesivir, showed efficacy in t...
by Kim Yun-mi  |  2020-02-04 16:39
라인
Boryung Holdings sets up US offshoot
Boryung Holdings said that it has established a subsidiary, Hayan Health Ne...
by Lee Han-soo  |  2020-02-03 16:28
라인
Drug firms minimize gatherings, hospital visits as coronavirus fear spreads
The local pharmaceutical industry is canceling annual events and meetings a...
by Jeong Sae-im  |  2020-02-03 15:21
라인
New coronavirus affect related stocks in different ways
Amid mounting fears of the new coronavirus infection, share prices of relat...
by Jeong Sae-im  |  2020-01-30 17:36
라인
Celltrion tops list of pharmaceutical brand reputation in January
Celltrion took the top place in the domestic brand reputation list of pharm...
by Jeong Sae-im  |  2020-01-30 16:10
여백
여백
여백
여백
Back to Top